List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006
ANNEX IVSupplementary provisions
ANNEX IV List of pharmaceutical intermediates, i.e. compounds used for the manufacture of finished pharmaceutical products, to be withdrawn from the list of products receiving duty-free treatment included in Annex 6 to Regulation (EC) No 1549/2006 ID No CN code CAS RN Name 677 2918 90 90 157283-68-6 isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(E)-(3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl}cyclopentyl]hept-5-enoate travoprost (INN) 603 2924 29 95 112522-64-2 4-acetamido-2'-aminobenzanilide tacedinaline (INN) 69 2924 29 95 166518-60-1 N-[(2,6-diisopropylphenoxy)sulfonyl]-2-(2,4,6-triisopropylphenyl)acetamide avasimibe (INN) 441 2928 00 90 53016-31-2 13-ethyl-17-alpha-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one oxime norelgestromin (INN) 833 2930 90 30 583-91-5 2-hydroxy-4-(methylthio)butyric acid desmeninol (INN) 273 2932 99 70 114870-03-0 methyl O-2-deoxy-6-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-beta-D-glucopyranuronosyl-(1,4)-O-2-deoxy-3,6-di-O-sulfo-2-(sulfoamino)-alpha-D-glucopyranosyl-(1,4)-O-2-O-sulfo-alpha-L-idopyranuronosyl-(1,4)-2-deoxy-2-(sulfoamino)-6-(hydrogen sulfate)-alpha-D-glucopyranoside, decasodium salt fondaparinux sodium (INN) 627 2933 39 99 75970-99-9 [1-(4-fluorobenzyl)-1H-benzimidazol-2-yl](4-piperidyl)amine tecastemizole (INN) 159 2933 39 99 100643-71-8 8-chloro-11-(4-piperidylidene)-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridine desloratadine (INN) 549 2933 39 99 168273-06-1 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide rimonabant (INN) 380 2933 39 99 193275-84-2 4-{4-[(11R)-3,10-dibromo-8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl]piperidinocarbonylmethyl}piperidine-1-carboxamide lonafarnib (INN) 397 2933 49 90 146362-70-1 2-{[1-(7-chloro-4-quinolyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonylamino}adamantane-2-carboxylic acid meclinertant (INN) 641 2933 59 95 147127-20-6 (R)-[2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methylphosphonic acid tenofovir (INN) 205 2933 59 95 149950-60-7 6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione emivirine (INN) 511 2933 59 95 153537-73-6 (S)-2-(4-{[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-ynyl)amino}-2-fluorobenzamido)-4-(1H-tetrazol-5-yl)butyric acid plevitrexed (INN) 686 2934 99 90 112984-60-8 (+-)-6-fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid ulifloxacin (INN) 33 2934 99 90 145514-04-1 (2R,4R)-4-(2,6-diamino-9H-purin-9-yl)-1,3-dioxolan-2-ylmethanol amdoxovir (INN) 513 2934 99 90 171228-49-2 4-[4-(4-{4-[(3R,5R)-5-(2,4-difluorophenyl)-5-(1H-1,2,4-triazol-1-ylmethyl)tetrahydrofuran-3-ylmethyloxy]phenyl}piperazin-1-yl)phenyl]-1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,2,4-triazol-5(4H)-one posaconazole (INN) 293 2934 99 90 184475-35-2 (3-chloro-4-fluorophenyl)[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine gefitinib (INN) 539 2935 00 90 150375-75-0 N'-{(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-3-hydroxy-2,3-dihydro-1H-indol-2-ylcarbonyl}-L-prolinamide relcovaptan (INN) 39 2935 00 90 161814-49-9 (3S)-tetrahydrofuran-3-yl (1S,2R)-3-[(4-aminophenylsulfonyl)(isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate amprenavir (INN) 115 2935 00 90 169590-42-5 4-[5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide celecoxib (INN) 654 2935 00 90 180200-68-4 4-(4-cyclohexyl-2-methyloxazol-5-yl)-2-fluorobenzenesulfonamide tilmacoxib (INN) 690 2935 00 90 181695-72-7 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide valdecoxib (INN) 520 2935 00 90 192329-42-3 (S)-N-hydroxy-2,2-dimethyl-4-[4-(4-pyridyloxy)phenylsulfonyl]-1,4-thiazinane-3-carboxamide prinomastat (INN) 364 3002 10 95 193700-51-5 SC-70935 leridistim (INN)